Richard A. Heyman, Director at Oric Pharmaceuticals, Inc. (ORIC), sold 6,700 shares at $12.00 ($80K) on 2026-01-16, disclosed to the SEC on 2026-01-20.
Scheduled sale ($80k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 3,200 | $38K | 47.8% |
| 2 | $12.00 | 3,500 | $42K | 52.2% |
| Total | $12.00 avg | 6,700 | $80K | 100% |
| Filing → |
| ELVN | SELL | 2026-02-19 | $32K | — | Filing → |
| ELVN | SELL | 2026-01-22 | $33K | — | Filing → |
| ELVN | SELL | 2026-01-12 | $656K | — | Filing → |